Brought to you by:
Vascular surgeons encouraged to consult talking points document on paclitaxel devices
Vascular surgeons are being encouraged to take consideration of a set of talking points about the risks and benefits of paclitaxel-equipped devices—which has been developed by a multispecialty panel of medical societies—in discussions with their patients. The document is the…
Sheahan: On professionals and professionalism
On March 19, 2019, I sat in the audience of the scientific sessions at the Annual Meeting of the Society for Clinical Vascular Surgery (SCVS). I was there with two of my trainees who were eagerly waiting to present their…
Your SVS: Storming into 2020 and horizons beyond
With significant progress made on many fronts in 2019, the Society for Vascular Surgery (SVS) is looking forward to the next horizon in 2020. In late January, I updated the Strategic Board of Directors on progress to date on strategic…
March 2020 is vascular recruitment month
Much has been made of the impending shortage of physicians in the United States, with ominous predictions that it could come as soon as 2030.1 The driving force behind the overall shortage is a menacing convergence of a rising, aging…